Chemocentryx reported $60.03M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amgen AMGN:US $ 14842M 257M
AstraZeneca AZN:LN 23649M 1427M
Bayer BAYN:GR € 28727M 801M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Chemocentryx CCXI:US $ 60.03M 4.65M
GlaxoSmithKline GSK:LN 22417M 1030M
Glaxosmithkline GSK:US $ 22417M 1030M
Macrogenics MGNX:US $ 68.86M 1.06M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Novartis NOVN:VX SF 29880M 247M
Omeros OMER:US $ 42.82M 4.88M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Takeda 4502:JP Y 1918750M 273984M
Teva Pharmaceutical TEVA:IT 11.82B 866M
YTE INCY:US $ 742.71M 82.39M